Lupin

Lupin gets tentative US FDA approval for Valbenazine capsules

Read more

Lupin receives EIR from US FDA for its injectable facility in Nagpur

Read more

Lupin launches neuro-rehabilitation center in Mumbai

Read more

LPC 150 Conclave to be held at NIPER Hyderabad on March 12, 2023

Read more

Lupin gets USFDA approval for Glycopyrrolate Injection, USP

Read more

USFDA gives tentative approval to Lupin’s Dolutegravir and Rilpivirine tablets

Read more

USFDA approves Prasugrel tablets by Lupin

Read more

Lupin and Exeltis announce reimbursement approval of NaMuscla

Read more

Lupin launches novel fixed-dose triple drug combination Difizma DPI to treat inadequately controlled asthma

Read more

Lupin Diagnostics launches regional reference laboratory in Indore

Read more